CAPTION: Shelby Senior, RN, unit manager on Bishop Rehabilitation and Nursing Center’s Covid-19 unit, is prepared to administer the new monoclonal antibody treatment available to residents
Advanced treatment for Covid-19 in the form of monoclonal antibody infusions has begun at VestraCare’s Bishop Rehabilitation and Nursing Center. To date, 11 residents have received the infusions and have experienced beneficial results. “The monoclonal antibody treatments have proven to be very effective, and we’re seeing a swift and noticeable improvement in the residents who received them,” stated Bishop’s Administrator Tim Reedy, LNHA. “We’re happy to be able to offer this progressive form of treatment at our facility.”
In November 2020, the FDA (Food and Drug Administration) issued EUA (emergency use authorization) for the use of monoclonal antibodies for the treatment of high-risk patients with mild to moderate Covid-19 symptoms at risk for progression to severe illness and hospitalization. The antibodies are made with proteins created in a laboratory and are designed to mimic the antibodies created in the body’s immune system to ward off the virus and fight infection.
Bishop Rehabilitation and Nursing Center provides 24-hour skilled nursing care, subacute rehabilitation and short-term respite care. For more information, visit http://www.bishopcare.com.